|
Real-time Estimate
Cboe BZX
12:52:50 14/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 9.600 USD | -1.13% |
|
+2.23% | -8.29% |
| 16/07 | Moderna advances its cancer therapy assessment, but the stock slides | |
| 01/06 | Immatics N.V. Announces Updated Clinical Data For IMA203CD8, IMA401, And Anzu-Cel PRAME Cell Therapies | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.13% | +2.23% | +4.33% | -10.75% | -8.29% | +57.87% | -20.77% | -19.75% | - | 132.71Cr | ||
| +2.07% | +10.05% | +31.65% | +47.13% | +79.09% | +77.41% | +106.53% | +16.62% | - | 7.01TCr | ||
| -0.87% | +0.08% | -0.68% | +9.78% | +5.25% | +36.96% | +65.04% | +182.97% | +5,378.58% | 5.49TCr | ||
| -3.60% | -3.47% | +17.23% | +8.44% | -26.48% | +4.13% | +473.77% | +443.08% | +920.33% | 2.89TCr | ||
| +0.04% | +12.56% | +20.44% | +35.67% | +45.42% | +54.67% | +5.47% | -61.93% | - | 2.39TCr | ||
| -0.91% | +1.29% | +2.55% | +0.15% | -2.97% | -18.10% | -14.03% | -75.52% | - | 2.33TCr | ||
| +0.35% | +8.24% | +12.45% | +125.44% | +241.04% | +252.94% | +466.50% | +1,800.42% | +864.12% | 1.84TCr | ||
| -0.59% | +7.88% | +6.38% | +20.25% | -0.10% | +40.87% | -20.12% | -31.36% | +78.73% | 1.88TCr | ||
| -0.57% | +6.85% | +1.74% | +14.04% | +33.99% | +30.20% | +580.70% | - | - | 1.61TCr | ||
| +0.96% | -2.66% | -9.33% | -0.94% | +15.93% | +32.01% | +136.22% | +177.95% | +372.21% | 1.25TCr | ||
| -0.88% | +1.08% | +17.06% | +11.40% | +30.67% | +333.99% | +195.19% | +43.35% | +1,317.57% | 1.23TCr | ||
| -4.46% | +0.87% | -3.05% | -0.79% | -11.60% | +37.84% | +196.81% | +506.63% | +6,228.09% | 1.24TCr | ||
| -4.50% | +8.53% | -3.95% | -21.79% | -15.98% | -45.31% | +642.17% | +85.54% | +117.70% | 1.2TCr | ||
| +1.47% | +8.48% | +6.53% | -20.31% | -8.32% | -33.80% | +208.79% | +135.99% | - | 1.2TCr | ||
| -1.65% | -8.87% | -9.84% | -3.98% | +16.70% | +101.06% | +131.00% | +130.64% | +510.29% | 1.05TCr | ||
| +0.24% | -0.06% | -1.90% | -13.07% | +14.58% | +25.19% | +119.41% | -26.34% | - | 898.66Cr | ||
| -1.91% | -1.12% | +9.10% | +34.01% | +212.15% | +487.70% | +768.45% | -32.17% | -12.78% | 917.8Cr | ||
| +0.04% | +0.69% | +0.99% | +125.44% | +81.51% | +180.81% | +401.75% | +279.58% | - | 895.83Cr | ||
| -0.94% | +0.71% | +4.00% | +9.33% | +28.54% | +87.99% | +28.93% | +127.85% | - | 887.62Cr | ||
| -0.84% | +5.26% | -1.09% | -5.46% | +289.14% | +173.23% | +316.49% | -31.51% | - | 820.31Cr | ||
| Average | -0.88% | +5.28% | +5.23% | +18.20% | +51.01% | +95.88% | +239.41% | +192.21% | +1,577.48% | 1.86TCr | |
| Weighted average by Cap. | -0.49% | +6.71% | +9.94% | +23.60% | +45.22% | +75.52% | +201.25% | +194.67% | +2,338.32% |
- Stock Market
- Stocks
- IMTX Stock
- Sector Immatics N.V.
Select your edition
All financial news and data tailored to specific country editions
















